All In Biotech

Drug Trial Radar · NCT07065305

Clinical Performance and Remineralization Potential of Self- Assembling Peptide P11-4 Containing Fluoride Versus Er, Cr: YSGG Laser Treatment and Micro Tensile Bond Strength of Giomer Restoration in Carious Lesions

Last checked: Nov 20, 2026Latest source record: Jul 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

21

Planned (sponsor's estimate)

Start

Sep 15, 2025

Primary completion

Sep 15, 2026

Study completion Sep 15, 2026

Sponsor

Lead sponsor
Al-Azhar UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 20 years, up to 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will be performed in two parts, in vivo and in vitro to assess the effect of the remineralization potential of self-assembling peptide P11-4 containing Fluoride on caries-affected dentin compared to untreated caries-affected dentin and the influence of Er, Cr: YSGG Laser treatment.

Conditions

  • Remineralization Potential
  • Dentin Caries

Interventions

  • Curodont Repair Fluoride Plus (Self-assembling peptide remineralization agent)P11-4 peptide, fluoride, mild acidic buffer (pH ~4.5) , Credentis AG, SwitzerlandDrug

    Pretreatment with Curodont Repair Fluoride Plus (P11-4 + fluoride)

  • Beautifil II LSDrug

    Application of Giomer restorative material following standard adhesive procedures without pretreatment.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Marginal integrity of restorationsTime frame: 6 months and 12 months
  2. Clinical longevity of restorationsTime frame: 6 and 12 months
  3. Overall clinical performance of restorationsTime frame: 6 and 12 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.